Bone Biologics (BBLG) Notes Payables (2013 - 2021)
Bone Biologics (BBLG) reported Notes Payables of $12.8 million for Q3 2021, up 10.07% year-over-year from $11.6 million in Q3 2020, and up 2.22% quarter-over-quarter from $12.5 million in Q2 2021.
Bone Biologics (BBLG) Notes Payables (2013 - 2021) Analysis & Trends
Bone Biologics (BBLG) has 9 years of Notes Payables data on file, last reported at $12.8 million in Q3 2021.
- Notes Payables for Q3 2021 came in at $12.8 million, up 10.07% year-over-year; the trailing twelve-month figure through Sep 2021 was $12.8 million (up 10.07% YoY), and the FY2020 annual result was $10609.0, changed N/A from the prior year.
- Notes Payables grew to $12.8 million in Q3 2021 per BBLG's latest filing, from $12.5 million in the prior quarter.
- Over five years, Notes Payables peaked at $12.8 million in Q3 2021 and troughed at $102.0 in Q2 2020.
- A 5-year average of $7.2 million and a median of $9.7 million in 2019 frame the typical range for Notes Payables.
- The sharpest annual moves came in 2020 and 2021: Notes Payables sank 100.0% in 2020, then jumped 12246164.71% in 2021.
- A 5-year view of Notes Payables shows it stood at $2.9 million in 2017, then surged by 211.65% to $9.0 million in 2018, then climbed by 24.44% to $11.2 million in 2019, then plunged by 99.91% to $10609.0 in 2020, then surged by 120249.67% to $12.8 million in 2021.
- Business Quant data shows BBLG's Notes Payables at $12.8 million in Q3 2021, $12.5 million in Q2 2021, and $11.9 million in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Bone Biologics | 1.47 Mn | 1.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 12.77 Mn |
| Jun 30, 2021 | 12.49 Mn |
| Mar 31, 2021 | 11.92 Mn |
| Dec 31, 2020 | 10,609.00 |
| Sep 30, 2020 | 11.60 Mn |
| Jun 30, 2020 | 102.00 |
| Mar 31, 2020 | 11.45 Mn |
| Sep 30, 2019 | 11.20 Mn |
| Jun 30, 2019 | 10.70 Mn |
| Mar 31, 2019 | 9.70 Mn |
| Dec 31, 2018 | 9.00 Mn |
| Jun 30, 2018 | 600,000.00 |
| Sep 30, 2017 | 2.89 Mn |
| Jun 30, 2017 | 2.11 Mn |
| Mar 31, 2017 | 1.56 Mn |
| Dec 31, 2016 | 1.20 Mn |
| Dec 31, 2015 | -533,343.00 |
| Mar 31, 2015 | 3.66 Mn |
| Dec 31, 2014 | 3.66 Mn |
| Sep 30, 2014 | 324,188.00 |